Concepedia

Publication | Open Access

The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib

DOIFull Paper Access

73

Citations

46

References

2018

Year

Karthick Vishwanathan, Paul A. Dickinson, Karen So, Karen Thomas, Yuh‐Min Chen, Javier de Castro, Anne‐Marie C. Dingemans, Hye Ryun Kim, Joo‐Hang Kim, Matthew Krebs,
British Journal of Clinical Pharmacology

Abstract

Osimertinib can be co-administered with CYP3A4 inhibitors, but strong CYP3A inducers should be avoided if possible.

References

YearCitations

Page 1